Here's my math.

Dilutions from 10/25/2013 to 6/30/2017:

https://investorshangout.com/post/view?id=4819511

Dilutions from 7/1/2017 to 2/7/2018:

https://m.investorshangout.com/post/view?id=4963550

Dilutions from 4/1/2018 to 5/9/2018:

https://investorshangout.com/post/view?id=5037952

Dilutions from 6/28/2018 to present:

"The Company received $2 million on signing the agreement selling 5,263,158 shares at price per share of $0.38 which was the closing price of the Company’s common stock on June 26, 2018."

http://www.ipharminc.com/press-release/2018/6...re-capital

8,890,379 + 14,700,000 + 2,600,000 + 6,600,000 + 900,000 + 8,000,000 + 5,263,158 = 46,953,537 shares

The answer to your question is ~47 million shares were issued to Aspire. Don't forget that Aspire can't short these shares. Now let's see your math.